hVIVO plc announced the appointment of Dr. Trevor Phillips as Executive Chairman, succeeding current Non-Executive Chairman, Jaime Ellertson who has held that position since June 2014. Jaime will remain on the board as a Non-Executive Director. Trevor will work closely with Kym Denny, CEO of hVIVO, to refine and focus the Company's strategy to drive the business forward. He has over thirty years' of experience in the pharmaceutical industry and has a proven track record in corporate development. He was previously Chief Operations Officer and President of US Operations, as well as a member of the Board, at Vectura Group plc. Prior to this, he served as Chief Executive Officer and Chief Operating Officer at Critical Therapeutics Inc. and has also held senior management positions at Sepracor Inc. Trevor was originally appointed a Non-Executive Director of hVIVO in June 2017 and will assume his new role on 13 November 2017.